Ultime notizie per BiomX (AMEX:PHGE) Azioni

BIOMX INC

BiomX

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

BiomX Inc

BiomX Inc Warrants (13/12/2023)

Piper Sandler analyst Nicole Miller Regan maintains Dave &amp; Buster's Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) with a Neutral and lowers the price target from $33 to $22.

News

Price Target

Analyst Ratings

PLAY

Piper Sandler Maintains Neutral on Dave & Buster's Enter, Lowers Price Target to $22

<ul>
<li>Janus Henderson will manage the $45 billion investment grade public fixed income asset portfolio for Guardian's general account, becoming Guardian's investment grade public fixed income asset manager</li>
<li>Guardian will receive equity warrants and other economic consideration, supporting a shared goal of accelerating growth and creating value</li>
<li>Guardian will commit up to $400 million of seed capital for Janus Henderson fixed income product innovation</li>
<li>Guardian and Janus Henderson will also co-develop proprietary, multi-asset solution model portfolios for Guardian's dually registered broker-dealer and registered investment advisor, Park Avenue Securities (PAS)</li>
</ul>
The Guardian Life Insurance Company of America&#xAE; ("Guardian"), one of America's largest life insurers and a leading provider of employee benefits, and Janus Henderson Group plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>, "Janus Henderson"))), a leading global asset manager, today announced an innovative strategic partnership, whereby Janus Henderson will become Guardian's investment grade public fixed income asset manager. Through the partnership, Janus Henderson will manage the $45 billion investment grade public fixed income portfolio for Guardian's general account, which will include investment grade corporates and securitized credit. As part of the agreement, Guardian investment professionals currently supporting the in-scope asset classes will have the opportunity to join Janus Henderson, providing continuity in the management of these assets while further enhancing Janus Henderson's specialized insurance investment capabilities.

Janus Henderson Group plc Ordinary Shares

Janus Henderson And Guardian Life Insurance Announce Strategic Partnership, With Janus Henderson Managing Guardian's Investment Grade Public Fixed Income Portfolio, Committing To $400M In Seed Capital For Fixed Income Innovation, And Co-Developing Multi-Asset Solutions

WIIM

NextDecade shares are trading higher after the company announced a 20-year LNG sale and purchase agreement to supply 1.2 million tonnes per year to a subsidiary of Saudi Aramco.

Piper Sandler analyst Crispin Love maintains Virtus Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRTS#NYSE">VRTS</a>) with a Overweight and lowers the price target from $252 to $216.

VRTS

Piper Sandler Maintains Overweight on Virtus Inv, Lowers Price Target to $216

BREA

Italian Football Federation Completed Review Of Brera Holdings' Acquisition Of Stake In S.S. Juve Stabia

Barclays analyst Matthew Bouley maintains Builders FirstSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) with a Overweight and lowers the price target from $165 to $151.

BLDR

Barclays Maintains Overweight on Builders FirstSource, Lowers Price Target to $151

PCRX

Pacira BioSciences shares are trading higher after HC Wainwright & Co. raised its price target on the stock from $48 to $65 and maintained a Buy rating.

CRMD

CorMedix shares are trading higher after the company issued Q1 preliminary revenue guidance above estimates.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Oppenheimer cut Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) price target from $350 to $300. Oppenheimer analyst Ken Wong maintained an Outperform rating. Autodesk shares closed at $243.62 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/ADSK/analyst-ratings">view this stock</a>.</li>
<li>B of A Securities slashed the price target for Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) from $75 to $70. B of A Securities analyst Robert Ohmes maintained an Underperform rating. Dollar Tree shares closed at $72.84 on Monday. <a href="https://www.benzinga.com/quote/DLTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird lowered Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) price target from $105 to $80. Baird analyst David Koning maintained an Outperform rating. Block shares closed at $50.47 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/XYZ/analyst-ratings">view this stock</a>.</li>
<li>Wells Fargo cut the price target for Ralph Lauren Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) from $275 to $240. Wells Fargo analyst Ike Boruchow upgraded the stock from Equal-Weight to Overweight. Ralph Lauren shares closed at $193.17 on Monday. <a href="https://www.benzinga.com/quote/RL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup cut the price target for Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from $53 to $48. Citigroup analyst Ariel Rosa upgraded the stock from Neutral to Buy. Knight-Swift Transportation shares closed at $39.30 on Monday. <a href="https://www.benzinga.com/quote/KNX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised Rocket Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) price target from $10 to $14. Barclays analyst Terry Ma upgraded the stock from Underweight to Equal-Weight. Rocket Companies shares settled at $14.66 on Monday. <a href="https://www.benzinga.com/quote/RKT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan cut Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) price target from $19 to $17. JP Morgan analyst Matthew Boss upgraded the stock from Neutral to Overweight. Levi Strauss shares closed at $13.50 on Monday. <a href="https://www.benzinga.com/quote/LEVI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies increased Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) price target from $53 to $64. Jefferies analyst David Windley upgraded the stock from Underperform to Hold. Centene shares closed at $61.35 on Monday.  <a href="https://www.benzinga.com/quote/CNC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised the price target for Rhythm Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) from $81 to $92. Canaccord Genuity analyst Whitney Ijem maintained a Buy rating. Rhythm Pharmaceuticals shares settled at $54.96 on Monday. <a href="https://www.benzinga.com/quote/RYTM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo raised Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) price target from $140 to $150. Wells Fargo analyst Ike Boruchow upgraded the stock from Equal-Weight to Overweight. Ross Stores shares closed at $127.88 on Monday. <a href="https://www.benzinga.com/quote/ROST/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ROST stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="452" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39-1024x452.png" alt="" class="wp-image-861945" style="width:682px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39-1024x452.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39-300x132.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39-768x339.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08091839/image-39.png 1398w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:<a href="https://www.benzinga.com/news/earnings/25/04/44678688/dow-falls-for-3rd-session-amid-trumps-tariff-threats-as-apple-tesla-decline-greed-index-remains-in-extreme-fear-zone"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44678688/dow-falls-for-3rd-session-amid-trumps-tariff-threats-as-apple-tesla-decline-greed-index-remains-in-extreme-fear-zone">Dow Falls For 3rd Session Amid Trump&#8217;s Tariff Threats As Apple, Tesla Decline: Greed Index Remains In &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

ADSK

DLTR

LEVI

ROST

RYTM

Ross Stores To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Tuesday

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.tetratech.com%2F&amp;esheet=54235234&amp;newsitemid=20250407434449&amp;lan=en-US&amp;anchor=Tetra+Tech%2C+Inc.&amp;index=1&amp;md5=8ddc3b3bbd432b1ff04b9c4c5a5b580a">Tetra Tech, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today the Government Services Administration awarded the Company a contract for broad service areas under the One Acquisition Solution for Integrated Services (OASIS+) unrestricted program. OASIS+ is the largest government-wide contract program designed to deliver professional services to federal agencies. The 5-year, multiple-award Indefinite Delivery Indefinite Quantity OASIS+ contract is a Best-in-Class vehicle open to all federal agencies and has an unlimited ceiling value.
Tetra Tech has been selected for multiple technical service areas to meet the diverse needs of federal agencies including management and advisory, research and development, technical and engineering, environmental, facilities, intelligence, and logistics services.

Contracts

TTEK

Tetra Tech Awarded OASIS+ Contract By The Government Services Administration For Broad Service Areas, Enabling Provision Of Management, Engineering, Environmental, And Other Professional Services To Federal Agencies Under Unlimited Ceiling Value Over 5-Years

CVRX

CVRx shares are trading lower after Canaccord Genuity cut its price target on the stock from $23 to $18.

Piper Sandler analyst Crispin Love maintains TriplePoint Venture Gwth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPVG#NYSE">TPVG</a>) with a Neutral and lowers the price target from $8 to $7.

TPVG

Piper Sandler Maintains Neutral on TriplePoint Venture Gwth, Lowers Price Target to $7

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="340" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08120537/brief-consumer-v3.1-11.png" alt="" class="wp-image-10004" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08120537/brief-consumer-v3.1-11.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08120537/brief-consumer-v3.1-11-300x113.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08120537/brief-consumer-v3.1-11-768x290.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
Foshan Haitian Flavouring and Food Co. Ltd.&nbsp;(603288.SH) last Thursday reported revenue and profit growth for 2024 amid a globalization drive to propel its business. The leading Shanghai-listed soy sauce and condiment maker is currently preparing for a Hong Kong listing to enhance its brand reputation and expand its reach beyond China.
Haitian reported its revenue rose 9.53% last year to 26.9 billion yuan ($3.7 billion) from 24.6 billion yuan in 2023, according to the annual report. Its 2024 net profit grew 12.75% to 6.34 billion yuan from 5.63 billion yuan a year earlier.
According to its Hong Kong listing prospectus, Haitian was the only top 10 global condiment company to achieve double-digit compound annual growth from 2013 to 2023. Haitian ranked first in the global soy sauce market with 6% share and 12.6% of the China market, and it is also the global leader in oyster sauce with 23.7% market share. The company has been the largest condiment company in China for 27 consecutive years by sales volume, and is a leader in fermentation technology, strain breeding and production equipment.
Haitian, whose history dates back more than 400 years, is making the Hong Kong listing to raise its profile outside China as part of an effort to consolidate its industry-leading position amid the growing influence of Chinese cuisine globally. The company spent over 840 million yuan on R&amp;D last year, accounting for 3.12% of its revenue, as it worked on initiatives such as deploying digital intelligence in its soy sauce brewing at one of its factories, which it calls the first and only "Lighthouse Factory" globally in soy sauce brewing.
By Doug Young

Asia

Equities

IPOs

Haitian Flavoring Reports Double-digit Profit Growth For 2024; Prepares For A Hong Kong IPO

Orders Reflecting Growing Trend of New Airline Customers Totaled over $6 Millionin the Last Calendar Year with Additional Orders Expected Throughout 2025
Flux Power Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>), a leading developer of advanced lithium-ion energy storage solutions for the electrification of commercial and industrial equipment, today provided an update on its significant presence within the airline industry's continued electrification of Ground Support Equipment ("GSE"). Over the past calendar year, six new large North American airlines have placed purchase orders for Flux Power's G-Series lithium-ion solutions to electrify their GSE fleets at 7 different locations in North America, further reflecting the industry's accelerating commitment to sustainability.
These new airline customers purchase orders totaling over $6 million in the last calendar year with more orders expected this year, and the approximately $20 million in total GSE orders, reflect a growing trend of major airlines transitioning away from lead acid and fossil fuel-powered GSE in favor of cleaner, more efficient lithium-ion solutions. As airlines continue to adopt sustainability initiatives and carbon-reduction strategies, Flux Power's energy solutions provide a reliable, high-performance alternative that enhances operational efficiency while lowering emissions and the total cost of ownership.
Averest Inc., Flux Power's trusted GSE sales and service provider, played a pivotal role in securing partnerships with these large airlines through their electric solutions expertise and strong commitment to customer satisfaction.
These purchase orders included Flux Power's innovative 80-volt, <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fluxpower.com%2Fhubfs%2FSA-813_Product%2520Brochure%2520G2-G80-Rev_B.pdf&amp;esheet=54235276&amp;newsitemid=20250408134931&amp;lan=en-US&amp;anchor=G80+series+batteries&amp;index=1&amp;md5=02936aab961e20cfdac60e475b0e5d80">G80 series batteries</a> and Flux Power's SkyEMS integrated telematics Cloud Software Platform that provides advanced data analysis capabilities, empowering customers with actionable insights for fleet optimization and operational efficiency. These batteries will power a range of essential ground support equipment including bag tractors and pushback tractors as part of the customers' fleet electrification strategy.

FLUX

Flux Power Holdings Secures Over $6M In Orders From Six New North American Airlines For G-Series Lithium-Ion Solutions To Electrify Ground Support Equipment, Reflecting Growing Trend Towards Sustainability And Carbon Reduction, With Additional Orders Expected In 2025

Piper Sandler analyst Crispin Love maintains SEI Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) with a Neutral and lowers the price target from $87 to $74.

SEIC

Piper Sandler Maintains Neutral on SEI Inv, Lowers Price Target to $74

Shareholder-Approved Merger Between Nxu And Verde Bioresins, Progressing Towards Close

CPRX

Catalyst Pharmaceuticals shares are trading higher after the company announced that Health Canada accepted its AGAMREE new drug submission with priority review.

AirJoule Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRJ#NASDAQ">AIRJ</a>) ("AirJoule Technologies" or the "Company"), the developer of the transformational AirJoule&#xAE; system for separating pure water from air, today announced an agreement with Arizona State University ("ASU"), which is widely recognized as an international leader in the field of atmospheric water harvesting research. Under the binding agreement, ASU will purchase one AirJoule&#xAE; A250TM unit, a high-capacity system capable of producing 250 liters of pure distilled water per day directly from ambient air.
AirJoule&#xAE; utilizes advanced sorbents and a dual-chamber vacuum system to separate water from air. The proprietary dual-chamber design allows internally generated heat to be re-used in the system, which significantly reduces external power requirements. AirJoule&#xAE; can also utilize low-grade waste heat from industrial operations to further reduce its energetics for separating moisture from air. Compared to conventional moisture removal systems, AirJoule&#xAE; is over 4x more efficient than refrigerant-based systems and over 8x more efficient than desiccant systems when utilizing low-grade waste heat.
The AirJoule&#xAE; A250TM unit purchased by ASU will be operated within the greater Phoenix area at various testing locations, where researchers will independently evaluate its performance across a range of real-world conditions, including arid climates and variable humidity levels. Phoenix, known for its hot desert climate, frequently experiences relative humidity levels below 20% – conditions that significantly impact the ability of conventional atmospheric water harvesting systems to function effectively. AirJoule&#xAE;'s enhanced capability to produce pure distilled water in these dry conditions significantly expands its potential for deployment in water-stressed regions around the world.

AIRJ

AirJoule Technologies Partners With Arizona State University To Supply High-Capacity AirJoule A250TM System For Water Harvesting Research, Demonstrating Over 4x Efficiency Compared To Traditional Moisture Removal Systems

As of April 8, 2025, three stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the<a href="https://www.benzinga.com/topic/rsi"> RSI is above 7</a>0, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Mesa Air Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESA#NASDAQ">MESA</a>)</h3>
<ul>
<li>On April 7, Mesa Air Group and Republic Airways Holdings Inc announced a merger agreement to create a major player in the regional airline market. "Today's announcement is an exciting next step in Mesa's more than 40-year history, one that represents the best outcome for our shareholders, employees, and all of our stakeholders," said Mesa's Chairman and CEO, Jonathan Ornstein. The company's stock gained around 39% over the past five days and has a 52-week high of $1.89.</li>
<li>RSI Value: 71.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>MESA Price Action: Shares of Mesa Air gained 54.9% to close at $1.10 on Monday.</li>
<li>Edge Stock Ratings: 24.10 Momentum score with Value at 85.64.</li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/mesa"><img loading="lazy" decoding="async" width="497" height="181" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08032054/image-31.png" alt="" class="wp-image-861294" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08032054/image-31.png 497w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08032054/image-31-300x109.png 300w" sizes="(max-width: 497px) 100vw, 497px" /></a></figure>
<h3 class="wp-block-heading">eLong Power Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>)</h3>
<ul>
<li>On March 25, Elong Power received staff determination notices from Nasdaq. The company's stock gained around 51% over the past five days and <a href="https://www.benzinga.com/quote/ELPW">has a 52-week high</a> of $12.60.</li>
<li>RSI Value: 74.1</li>
<li>ELPW Price Action: Shares of eLong Power gained 18.6% to close at $1.06 on Monday.</li>
</ul>
<h3 class="wp-block-heading">Markforged Holding Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>)</h3>
<ul>
<li>On March 28, Markforged Holding posted downbeat quarterly sales. &#8220;We are encouraged by the continued adoption of our next generation product line, despite the challenging market conditions that we are facing,&#8221; said Shai Terem, President and CEO of Markforged. The company's stock gained around 94% over the past month and has a <a href="https://www.benzinga.com/quote/MKFG">52-week high</a> of $7.50.</li>
<li>RSI Value: 73.1</li>
<li>MKFG Price Action: Shares of Markforged Holding fell 0.9% to close at $4.55 on Monday.</li>
</ul>
Learn more about BZ Edge Rankings—click to see scores for other <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">stocks in the sector and see how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44669062/top-3-health-care-stocks-that-may-crash-in-q2">Top 3 Health Care Stocks That May Crash In Q2</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

ELPW

MESA

MKFG

Top 3 Industrials Stocks You May Want To Dump This Month

SGBX

Safe & Green Holdings Corp.'s Olenox Subsidiary Purchases 51% Stake In Winchester Oil and Gas

Press Releases

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

BiomX Announces a Mandatory Unit Separation

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

Earnings

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards

Financing

BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

Comments

BiomX

Notizie

Ultime notizie per BiomX (AMEX:PHGE) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO